International Patent: LONG-ACTING FORMULATIONS OF HETEROCYCLIC GLP1 RECEPTOR AGONISTS

GENEVA, July 2 -- EXAVIR THERAPEUTICS, INC. filed a patent application (US2025/060685) for “LONG-ACTING FORMULATIONS OF HETEROCYCLIC GLP1 RECEPTOR AGONISTS”. With publication no. WO/2026/136898, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/437

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....